These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37808069)

  • 41. Key factors influencing multidrug-resistant tuberculosis in patients under anti-tuberculosis treatment in two centres in Burundi: a mixed effect modelling study.
    Iradukunda A; Ndayishimiye GP; Sinarinzi D; Odjidja EN; Ntakaburimvo N; Nshimirimana I; Izere C
    BMC Public Health; 2021 Nov; 21(1):2142. PubMed ID: 34814876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis.
    Ma JB; Zeng LC; Ren F; Dang LY; Luo H; Wu YQ; Yang XJ; Li R; Yang H; Xu Y
    BMC Infect Dis; 2023 May; 23(1):289. PubMed ID: 37147607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automated Pulmonary Tuberculosis Severity Assessment on Chest X-rays.
    Kantipudi K; Gu J; Bui V; Yu H; Jaeger S; Yaniv Z
    J Imaging Inform Med; 2024 Apr; ():. PubMed ID: 38587769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients.
    Shi W; Wu J; Tan Q; Hu CM; Zhang X; Pan HQ; Yang Z; He MY; Yu M; Zhang B; Xie WP; Wang H
    Infect Drug Resist; 2019; 12():1265-1276. PubMed ID: 31190914
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
    Goswami A; Chakraborty U; Mahapatra T; Mahapatra S; Mukherjee T; Das S; Das A; Dey SK; Ray S; Bhattacharya B; Pal NK
    PLoS One; 2014; 9(10):e109563. PubMed ID: 25289974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand.
    Pongpeeradech N; Kasetchareo Y; Chuchottaworn C; Lawpoolsri S; Silachamroon U; Kaewkungwal J
    PLoS One; 2022; 17(7):e0271130. PubMed ID: 35895742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proposing a novel multi-instance learning model for tuberculosis recognition from chest X-ray images based on CNNs, complex networks and stacked ensemble.
    Khatibi T; Shahsavari A; Farahani A
    Phys Eng Sci Med; 2021 Mar; 44(1):291-311. PubMed ID: 33616887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Machine learning and radiomics for the prediction of multidrug resistance in cavitary pulmonary tuberculosis: a multicentre study.
    Li Y; Wang B; Wen L; Li H; He F; Wu J; Gao S; Hou D
    Eur Radiol; 2023 Jan; 33(1):391-400. PubMed ID: 35852573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB.
    Kliiman K; Altraja A
    Eur Respir J; 2009 May; 33(5):1085-94. PubMed ID: 19164345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
    Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
    PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generalization Challenges in Drug-Resistant Tuberculosis Detection from Chest X-rays.
    Karki M; Kantipudi K; Yang F; Yu H; Wang YXJ; Yaniv Z; Jaeger S
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
    Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N
    BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosis.
    Muyoyeta M; Kasese NC; Milimo D; Mushanga I; Ndhlovu M; Kapata N; Moyo-Chilufya M; Ayles H
    BMC Infect Dis; 2017 Apr; 17(1):301. PubMed ID: 28438139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
    BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of a radiological severity score to predict treatment outcome in adults with pulmonary tuberculosis.
    Kriel M; Lotz JW; Kidd M; Walzl G
    Int J Tuberc Lung Dis; 2015 Nov; 19(11):1354-60. PubMed ID: 26467588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
    Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
    Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.